FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012852017> ?p ?o ?g. }

• W2012852017 endingPage "249" @default.
• W2012852017 startingPage "241" @default.
• W2012852017 abstract "The effects of the S enantiomer of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, alone or in combination with a functional NMDA receptor antagonist, (+)-HA966 were studied on the spinal c-Fos protein expression in the carrageenan model of inflammatory nociception. One hour 30min after intraplantar carrageenan in awake rats, c-Fos immunoreactive (c-Fos-IR) nuclei were preferentially located in the laminae I-II and V-VI of the spinal dorsal horn, i.e., spinal areas containing numerous neurons responding exclusively, or not, to peripheral nociceptive stimuli. RB101(S) (5, 10, 20 and 40mg/kg i.v.) dose-dependently reduced the total number of carrageenan-evoked c-Fos-IR nuclei (r=0.63, P<0.01), with 49+/-3% reduction (P<0.001) for the highest dose. Two highest doses of RB101(S) (20 and 40mg/kg) significantly reduced the number of carrageenan-evoked c-Fos-IR nuclei in both superficial I-II (32+/-7% and 36+/-5% reduction, respectively, P<0.05 for both) and deep V-VI (42+/-6% and 61+/-2% reduction, respectively, P<0.001 for both) laminae. The effects of RB101(S) were naloxone-reversible. Combination of low doses of RB101(S) (2.5 or 10mg/kg i.v.) and an inactive dose of (+)-HA966 (2.5mg/kg s.c.) produced supra-additive effects (39+/-4% and 51+/-5% reduction of the total number of c-Fos-IR nuclei, respectively, P<0.001 for both). These effects were partially reversed by naloxone. These results provide evidence for the potent effects of combination of RB101(S) and (+)-HA966. Considering the absence of major opioid side effects of RB101(S) and the marked increase of its antinociceptive effects by NMDA receptor antagonist, this type of drug combination could have beneficial therapeutical application." @default.
• W2012852017 created "2016-06-24" @default.
• W2012852017 creator A5032132304 @default.
• W2012852017 creator A5056963078 @default.
• W2012852017 creator A5068784944 @default.
• W2012852017 creator A5078518818 @default.
• W2012852017 creator A5091794495 @default.
• W2012852017 date "2003-06-01" @default.
• W2012852017 modified "2023-10-18" @default.
• W2012852017 title "Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord" @default.
• W2012852017 cites W1589136255 @default.
• W2012852017 cites W1761965274 @default.
• W2012852017 cites W1965040375 @default.
• W2012852017 cites W1977831505 @default.
• W2012852017 cites W1985782583 @default.
• W2012852017 cites W1993877941 @default.
• W2012852017 cites W1999222018 @default.
• W2012852017 cites W1999483556 @default.
• W2012852017 cites W2001026574 @default.
• W2012852017 cites W2011894583 @default.
• W2012852017 cites W2011903568 @default.
• W2012852017 cites W2015621856 @default.
• W2012852017 cites W2024173492 @default.
• W2012852017 cites W2038994511 @default.
• W2012852017 cites W2041438513 @default.
• W2012852017 cites W2047920258 @default.
• W2012852017 cites W2050060946 @default.
• W2012852017 cites W2059430835 @default.
• W2012852017 cites W2061225812 @default.
• W2012852017 cites W2066853239 @default.
• W2012852017 cites W2069057248 @default.
• W2012852017 cites W2076068956 @default.
• W2012852017 cites W2079404537 @default.
• W2012852017 cites W2083900705 @default.
• W2012852017 cites W2087454739 @default.
• W2012852017 cites W2089485556 @default.
• W2012852017 cites W2093327340 @default.
• W2012852017 cites W2095549579 @default.
• W2012852017 cites W2097593809 @default.
• W2012852017 cites W2125350295 @default.
• W2012852017 cites W2131279396 @default.
• W2012852017 cites W2138512124 @default.
• W2012852017 cites W2143046795 @default.
• W2012852017 cites W2145881669 @default.
• W2012852017 cites W2165417187 @default.
• W2012852017 cites W4232614478 @default.
• W2012852017 cites W4298446485 @default.
• W2012852017 doi "https://doi.org/10.1016/s1090-3801(02)00122-2" @default.
• W2012852017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12725847" @default.
• W2012852017 hasPublicationYear "2003" @default.
• W2012852017 type Work @default.
• W2012852017 sameAs 2012852017 @default.
• W2012852017 citedByCount "5" @default.
• W2012852017 countsByYear W20128520172012 @default.
• W2012852017 countsByYear W20128520172016 @default.
• W2012852017 crossrefType "journal-article" @default.
• W2012852017 hasAuthorship W2012852017A5032132304 @default.
• W2012852017 hasAuthorship W2012852017A5056963078 @default.
• W2012852017 hasAuthorship W2012852017A5068784944 @default.
• W2012852017 hasAuthorship W2012852017A5078518818 @default.
• W2012852017 hasAuthorship W2012852017A5091794495 @default.
• W2012852017 hasConcept C104317684 @default.
• W2012852017 hasConcept C118552586 @default.
• W2012852017 hasConcept C134018914 @default.
• W2012852017 hasConcept C150194340 @default.
• W2012852017 hasConcept C15490471 @default.
• W2012852017 hasConcept C170493617 @default.
• W2012852017 hasConcept C185592680 @default.
• W2012852017 hasConcept C2776885963 @default.
• W2012852017 hasConcept C2777803847 @default.
• W2012852017 hasConcept C2778122271 @default.
• W2012852017 hasConcept C2778750930 @default.
• W2012852017 hasConcept C2779245659 @default.
• W2012852017 hasConcept C2780323455 @default.
• W2012852017 hasConcept C2780775167 @default.
• W2012852017 hasConcept C2781063702 @default.
• W2012852017 hasConcept C2781227287 @default.
• W2012852017 hasConcept C42219234 @default.
• W2012852017 hasConcept C55493867 @default.
• W2012852017 hasConcept C61174792 @default.
• W2012852017 hasConcept C67018056 @default.
• W2012852017 hasConcept C71924100 @default.
• W2012852017 hasConcept C98274493 @default.
• W2012852017 hasConceptScore W2012852017C104317684 @default.
• W2012852017 hasConceptScore W2012852017C118552586 @default.
• W2012852017 hasConceptScore W2012852017C134018914 @default.
• W2012852017 hasConceptScore W2012852017C150194340 @default.
• W2012852017 hasConceptScore W2012852017C15490471 @default.
• W2012852017 hasConceptScore W2012852017C170493617 @default.
• W2012852017 hasConceptScore W2012852017C185592680 @default.
• W2012852017 hasConceptScore W2012852017C2776885963 @default.
• W2012852017 hasConceptScore W2012852017C2777803847 @default.
• W2012852017 hasConceptScore W2012852017C2778122271 @default.
• W2012852017 hasConceptScore W2012852017C2778750930 @default.
• W2012852017 hasConceptScore W2012852017C2779245659 @default.
• W2012852017 hasConceptScore W2012852017C2780323455 @default.
• W2012852017 hasConceptScore W2012852017C2780775167 @default.
• W2012852017 hasConceptScore W2012852017C2781063702 @default.

• next